C1orf64 | Chromosome 1 open reading frame 64 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C1orf95 | Chromosome 1 open reading frame 95 | Predicted membrane proteins
| | | | | Tissue enhanced |
C3orf80 | Chromosome 3 open reading frame 80 | Predicted membrane proteins
| | | | | Tissue enhanced |
CA11 | Carbonic anhydrase XI | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CA14 | Carbonic anhydrase XIV | Enzymes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CABP7 | Calcium binding protein 7 | Predicted membrane proteins
| | | | | Tissue enhanced |
CACNA1A | Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
CACNA1G | Calcium channel, voltage-dependent, T type, alpha 1G subunit | FDA approved drug targets Plasma proteins Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
CACNA1I | Calcium channel, voltage-dependent, T type, alpha 1I subunit | FDA approved drug targets Plasma proteins Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
CACNA2D3 | Calcium channel, voltage-dependent, alpha 2/delta subunit 3 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CACNB4 | Calcium channel, voltage-dependent, beta 4 subunit | Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Transporters
| | | | | Tissue enhanced |
CACNG5 | Calcium channel, voltage-dependent, gamma subunit 5 | Predicted membrane proteins
| | | | | Tissue enhanced |
CADM4 | Cell adhesion molecule 4 | Predicted membrane proteins
| | | | | Tissue enhanced |
CADPS | Ca++-dependent secretion activator | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
CALHM1 | Calcium homeostasis modulator 1 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CALN1 | Calneuron 1 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CAMK1G | Calcium/calmodulin-dependent protein kinase IG | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CAMK2N1 | Calcium/calmodulin-dependent protein kinase II inhibitor 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CAMKK1 | Calcium/calmodulin-dependent protein kinase kinase 1, alpha | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
CBLN4 | Cerebellin 4 precursor | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CCDC177 | Coiled-coil domain containing 177 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CCDC184 | Coiled-coil domain containing 184 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CCDC85A | Coiled-coil domain containing 85A | Predicted secreted proteins
| | | | | Tissue enhanced |
CCK | Cholecystokinin | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CCSAP | Centriole, cilia and spindle-associated protein | Predicted intracellular proteins
| | | | | Tissue enhanced |
CDH4 | Cadherin 4, type 1, R-cadherin (retinal) | Predicted membrane proteins
| | | | | Tissue enhanced |
CDH7 | Cadherin 7, type 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
CDK5R1 | Cyclin-dependent kinase 5, regulatory subunit 1 (p35) | Predicted intracellular proteins
| | | | | Tissue enhanced |
CDKL5 | Cyclin-dependent kinase-like 5 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
CDR1 | Cerebellar degeneration-related protein 1, 34kDa | Predicted intracellular proteins
| | | | | Tissue enhanced |
CELF3 | CUGBP, Elav-like family member 3 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CELSR2 | Cadherin, EGF LAG seven-pass G-type receptor 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CELSR3 | Cadherin, EGF LAG seven-pass G-type receptor 3 | G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CGREF1 | Cell growth regulator with EF-hand domain 1 | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CHADL | Chondroadherin-like | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CHI3L1 | Chitinase 3-like 1 (cartilage glycoprotein-39) | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CHL1 | Cell adhesion molecule L1-like | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CHRNA4 | Cholinergic receptor, nicotinic, alpha 4 (neuronal) | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CHST1 | Carbohydrate (keratan sulfate Gal-6) sulfotransferase 1 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
CHST6 | Carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 6 | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
CLCN4 | Chloride channel, voltage-sensitive 4 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CLIP3 | CAP-GLY domain containing linker protein 3 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CNGB1 | Cyclic nucleotide gated channel beta 1 | Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CNIH3 | Cornichon family AMPA receptor auxiliary protein 3 | Predicted membrane proteins
| | | | | Tissue enhanced |
CNNM1 | Cyclin and CBS domain divalent metal cation transport mediator 1 | Predicted membrane proteins
| | | | | Tissue enhanced |
CNR1 | Cannabinoid receptor 1 (brain) | FDA approved drug targets G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CNTN1 | Contactin 1 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CNTNAP1 | Contactin associated protein 1 | Predicted membrane proteins
| | | | | Tissue enhanced |
CNTNAP5 | Contactin associated protein-like 5 | Predicted membrane proteins
| | | | | Tissue enhanced |
COL11A2 | Collagen, type XI, alpha 2 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |